Officials state the “probability of serious adverse health consequences is remote.”
The U.S. Food and Drug Administration (FDA) announced the recall of almost a million bottles of heart and kidney medications after “unexpected foreign matter” was discovered in a sampling from identified lots. Drug manufacturer Amgen issued a recall for the heart medication Corlanor (ivabradine) and the kidney medication Sensipar (cinacalcet), affecting over 944,000 bottles.
Health officials determined that the risk to the public is low, since the FDA recall is a Class II. This classification means the medication could “cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
The drug maker reported that the tablets were distributed between October 28, 2021, and December 30, 2025, with expiration dates ranging from August 2026 to December 2028.
As the Lord Leads, Pray with Us…
- For Acting Commissioner Kyle Diamantas to be led by the Lord as he heads the FDA.
- For U.S. health officials as they seek to ensure the safety of medications available to the public.
Sources: News Nation Now, Fox Business, The Hill
